Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00368615
Status:
RECRUITING
Last Update Posted:
2024-01-23
First Post:
2006-08-24
Brief Title:
Characterization of the Melanoma-Specific Immune Response
Sponsor:
Organization:
University of California Davis
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Peripheral blood will be collected prior to initiation of chemotherapy There will be no more than two blood draws per subject Most subjects will receive a single blood draw however some may be asked to return for an additional blood draw if investigators were unable to isolate melanoma-specific immune cells after the first blood draw Two separate blood draws will be the maximum
Enrollment Count:
20
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Control |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 2436 |
Who Masked List: